Jason Brunetta
Biographic Data
| ID | 9403319 |
|---|---|
| NAME | Jason Brunetta |
| GIVEN NAMES | Jason |
| FAMILY NAME | Brunetta |
| SIGNATURE | BRUNETTA J |
| AFFILIATIONS | Canadian Institutes of Health Research |
| ORCID | 0000-0002-0506-8616 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2009 |
| H-INDEX | 0 |
Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy
The long-term safety and efficacy of products used in the correction of HIV-associated facial lipoatrophy (FLA) are largely unknown. The purpose of this study was to describe the long-term efficacy and safety of polyalkylimide gel (PAIG) in the treatment of HIV-associated FLA. In this open-label, randomized, single-center study, 31 HIV-positive individuals (median age 48 years (interquartile ranges (IQR) 45, 55, 97% male) with FLA were randomized…
No prominent works on this page.
Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy
The long-term safety and efficacy of products used in the correction of HIV-associated facial lipoatrophy (FLA) are largely unknown. The purpose of this study was to describe the long-term efficacy and safety of polyalkylimide gel (PAIG) in the treatment of HIV-associated FLA. In this open-label, randomized, single-center study, 31 HIV-positive individuals (median age 48 years (interquartile ranges (IQR) 45, 55, 97% male) with FLA were randomized…
Adverse effect (1 work) · Antiretroviral therapy (1 work) · Anxiety (1 work) · Dermatological and COVID-19 studies (1 work) · Herpesvirus Infections and Treatments (1 work) · Internal Medicine (1 work) · Interquartile range (1 work) · Lipoatrophy (1 work) · Medicine (1 work) · Physical therapy (1 work)